Hasoon Jamal, Rothkrug Alexander, Chen Grant H, Yong R Jason, Robinson Christopher L
Department of Anesthesiology, Critical Care, and Pain Medicine The University of Texas Health Science Center at Houston.
Carolinas Pain Center.
Orthop Rev (Pavia). 2025 Aug 20;17:143096. doi: 10.52965/001c.143096. eCollection 2025.
Chronic knee pain has seen a significant rise over the past two decades, leading to increased functional limitations, mobility challenges, and decreased quality of life. Peripheral nerve stimulation (PNS) is an alternative management approach for chronic knee pain across various conditions. PNS involves implanting an electrode near a targeted nerve to deliver electrical stimulation, which interrupts pain signals, providing pain relief. This study evaluates the effectiveness of a 60-day PNS system in treating chronic knee pain and includes a comparison to a control group receiving conventional medical management (CMM).
This retrospective database and chart review study aimed at evaluating the effectiveness of a 60-day PNS system for managing chronic knee pain. Data were sourced from the device manufacturer's database, which included treatment records from two experienced interventional chronic pain physicians. The analysis focused on patients treated with the 60-day PNS therapy for chronic knee pain. The patient population consisted of individuals who received the PNS therapy specifically for knee pain under the care of the two experienced interventional chronic pain physicians, ensuring consistency in treatment application. Additionally, a chart review of 12 patients with similar pain complaints treated with CMM during the same time period was conducted to serve as a comparison group. Responder status was defined as achieving ≥ 50% pain relief.
Eighteen patients were identified who underwent PNS-therapy, and 94.4% (17/18) of the patients achieved ≥ 50% pain relief (responders) following the 60-day percutaneous PNS therapy. The weighted average of relief among responders was determined to be 82.3%. In the CMM control group, only 33.3% (4/12) of patients met the responder threshold, with an average relief of 61.3% among responders.
The study findings suggest that a 60-day percutaneous PNS targeting lower extremity nerves can effectively manage chronic knee pain. Further research is needed to determine the long-term efficacy of this treatment for various pain conditions.
在过去二十年中,慢性膝关节疼痛显著增加,导致功能受限加剧、行动不便,并降低了生活质量。外周神经刺激(PNS)是针对各种情况下慢性膝关节疼痛的一种替代管理方法。PNS包括在目标神经附近植入电极以传递电刺激,从而中断疼痛信号,缓解疼痛。本研究评估了60天PNS系统治疗慢性膝关节疼痛的有效性,并与接受传统医疗管理(CMM)的对照组进行了比较。
这项回顾性数据库和图表审查研究旨在评估60天PNS系统管理慢性膝关节疼痛的有效性。数据来自设备制造商的数据库,其中包括两位经验丰富的介入性慢性疼痛医生的治疗记录。分析重点是接受60天PNS治疗慢性膝关节疼痛的患者。患者群体包括在两位经验丰富的介入性慢性疼痛医生的护理下专门因膝关节疼痛接受PNS治疗的个体,以确保治疗应用的一致性。此外,对同期接受CMM治疗的12名有类似疼痛主诉的患者进行了图表审查,作为对照组。缓解状态定义为疼痛缓解≥50%。
确定了18名接受PNS治疗的患者,94.4%(17/18)的患者在60天经皮PNS治疗后疼痛缓解≥50%(缓解者)。缓解者的加权平均缓解率为82.3%。在CMM对照组中,只有33.3%(4/12)的患者达到缓解阈值,缓解者的平均缓解率为61.3%。
研究结果表明,针对下肢神经的60天经皮PNS可以有效管理慢性膝关节疼痛。需要进一步研究以确定这种治疗对各种疼痛状况的长期疗效。